Stay updated on Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.

Latest updates to the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe history now includes the latest site revision label, v3.6.2, replacing the prior v3.6.0. This reflects an internal deployment update and does not affect trial data or content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.6.0 was added to the study record, along with a note that the study is no longer looking for participants. The previous revision entry v3.5.5 has been removed from the history.SummaryDifference0.6%

- Check23 days agoChange DetectedThe history shows a new site revision (v3.5.5) replacing the previous revision, indicating a software release or UI update rather than changes to the study information.SummaryDifference0.1%

- Check44 days agoChange DetectedRecord History now includes a new version entry labeled Revision: v3.5.4. The previous entry Revision: v3.5.3 has been removed, reflecting an administrative update to the page's version history.SummaryDifference0.1%

- Check59 days agoChange DetectedThe revision tag in the record history was updated from v3.5.2 to v3.5.3, indicating a minor update to the page version history. It does not reflect changes to study content or results.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study record history.SummaryDifference0.1%

Stay in the know with updates to Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.